Redwood City, CA — November 7, 2025 — Leads & Copy — Biotricity Inc. (OTCQB:BTCY) will host its Fiscal 2026 Second Quarter Financial Results and Business Update Call on November 14, 2025, at 4:30 PM Eastern Time, according to a press release issued today.
Biotricity, an innovative Technology-as-a-Service (TaaS) company, is committed to redefining the healthcare industry with its remote monitoring and diagnostic solutions. The company has announced continued strength and progress in its financial performance.
The company’s Founder and CEO, Dr. Waqaas Al-Siddiq, and CFO, John Ayanoglou, will deliver remarks, followed by a Q&A session where they will address questions from investors.
The event details are as follows:
Event: Biotricity Fiscal 2026 Second Quarter Financial Results and Business Update Call
Date: Friday, November 14, 2025
Time: 4:30 PM ET (1:30 PM PT)
To access the call:
Toll Free: 1-877-269-7751
International: 1-201-389-0908
Webcast URL: https://viavid.webcasts.com/starthere.jsp?ei=1740411&tp_key=f4feb0c9ef
Investors can access the webcast 15 minutes before the call to register. The call will be in listen-only mode.
A replay of the call will be available approximately 3 hours after the live call via the Investors section of the Biotricity website.
Replay details:
Toll Free Replay Number: 1-844-512-2921
International: 1-412-317-6671
Replay Access ID: 13756814
Expiration: Friday, November 28, 2025, at 11:50 PM ET
Biotricity is reforming the healthcare market by bridging the gap in remote monitoring and chronic care management, offering diagnostic and post-diagnostic solutions for chronic conditions. The company develops comprehensive remote health monitoring solutions for the medical and consumer markets.
Biotricity Investor Relations
Investors@biotricity.com
Source: Biotricity Inc.
